Table 1 Baseline Characteristics
Docetaxel/Oxaliplatin (n = 44) | ||
|---|---|---|
Patient Characteristics | Number of Patients | Percent |
Sex | ||
Male | 29 | 65.9 |
Female | 15 | 34.1 |
Age (years) | ||
Median (and range) | 66.5 | 38–76 |
Karnofsky performance status score (n = 43) | ||
100 % | 9 | 20.9 |
90 % | 21 | 48.8 |
80 % | 13 | 30.2 |
Prior surgery | ||
No | 26 | 59 |
Curative Intention | 9 | 20.5 |
Palliative | 9 | 20.5 |
Prior radiotherapy | ||
Yes | 3 | 6.8 |
No | 41 | 93.2 |
Location of the primary | ||
Head | 26 | 59.1 |
Body | 10 | 22.7 |
Tail | 8 | 18.2 |
Disease extension | ||
Locally advanced | 8 | 18.2 |
Metastatic | 36 | 81.8 |
Metastatic sitesa | ||
Liver | 30 | 68.1 |
Lymphnodes | 10 | 22.7 |
Lung | 7 | 15.9 |
Bone | 2 | 4.5 |
Median duration of first line therapy (mts) | 4.5 | 95 % CI 2.1–7.25 |